Preference for hip protectors among older adults at high risk for osteoporotic fractures

Journal of Rheumatology

Volumn 33, Issue 10, 2006, Pages 2064-2068

  Fraenkel, Liana ^a   Gulanski, Barbara ^a   Wittink, Dick R ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Management and Marketing ^*

Author keywords

Hip protectors; Osteoporosis; Patient preferences

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

AGED; AGING; ARTICLE; CHOICE BASED CONJOINT ANALYSIS; COMPARATIVE STUDY; COMPUTER PROGRAM; DECISION MAKING; DRUG DOSE REGIMEN; FEMALE; FRAGILITY FRACTURE; HEALTH INSURANCE; HEARTBURN; HIGH RISK POPULATION; HIP PROTECTOR; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; QUESTIONNAIRE; RISK REDUCTION; STOMACH PAIN; TREATMENT OUTCOME; TREATMENT REFUSAL;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; DIPHOSPHONATES; FEMALE; HIP FRACTURES; HUMANS; MALE; OSTEOPOROSIS; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; PROTECTIVE DEVICES; QUESTIONNAIRES; RISK FACTORS;

EID: 33750001416     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002;359:1761-7.
2. Wehren LE, Magaziner J. Hip fracture: risk factors and outcomes. Curr Osteoporos Rep 2003;1:78-85.
3. Parker MJ, Gillespie WJ, Gillespie LD. Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review. BMJ 2006;332:571-4.
4. Kannus P, Parkkari J, Nieini S, et al. Prevention of hip fracture in elderly people with use of a hip protector. N Engl J Med 2000;343:1506-13.
5. Heikinheimo R, Jalonen-Mannikko A, Asumaniemi H, Lehtomaki E. External hip protectors in home-dwelling older persons. Aging Clin Exp Res 2004;16:41-3.
6. Singh S, Sun H, Anis AH. Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents. J Rheumatol 2004;31:1607-13.
7. Segui-Gomez M, Keuffel E, Frick KD. Cost and effectiveness of hip protectors among the elderly. Int J Technol Assess Health Care 2002;18:55-66.
8. Cameron ID, Stafford B, Cumming RG, et al. Hip protectors improve falls self-efficacy. Age Ageing 2000;29:57-62.
9. Sawka AM, Boulos P, Beattie K, et al. Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials. Osteoporos Int 2005;16:1461-74.
10. van Schoor NM, Asma G, Smit JH, Bouter LM, Lips P. The Amsterdam hip protector study: compliance and determinants of compliance. Osteoporos Int 2003;14:353-9.
11. Cramer JA, Amonkar MM, Hebborn A, Suppapanya N. Assessing the relationship between bisphosphonate dosing regimen and treatment adherence among post-menopausal osteoporotic women [abstract]. Arthritis Rheum 2004;50 Suppl:S294.
12. Bocuzzi SJ, Foltz SH, Omar MA, Kahler KH, Gutierrez B. Adherence and persistence associated with the pharmacologic treatment of osteoporosis [abstract]. Osteoporos Int 2005;2005:16(suppl 3):S24.
13. Solomon DH, Avorn J, Katz JN, et al. Compliance with osteoporosis medication. Arch Intern Med 2005;165:2414-9.
14. Orme B. CBC/web analysis module and market simulator. Sequim: Sawtooth Software Inc.; 2001.
15. Black DM, Steinbuch M, Palermo L, et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporosis Int 2001;12:519-28.
16. Ganther JM, Wiederholt JB, Kreling DH. Measuring patients' medical care preferences: care seeking versus self-treating. Med Decis Making 2001;21:133-40.
17. Orme B. Hierarchical Bayes regression analysis: technical paper. Technical Paper Series. Sequim: Sawtooth Software; 2003.
18. Braddock CH, 3rd, Edwards KA, Hasenberg NM, Laidley TL, Levinson W. Informed decision making in outpatient practice: time to get back to basics. JAMA 1999;282:2313-20.
19. Rothman AJ, Kiviniemi MT. Treating people with information: an analysis and review of approaches to communicating health risk information. Monogr Natl Cancer Inst 1999;25:44-51.